Market Cap ₹21479 Cr.
Stock P/E 104.9
P/B 6.1
Current Price ₹430
Book Value ₹ 70.1
Face Value 10
52W High ₹558.3
Dividend Yield 0.47%
52W Low ₹ 312.3
Aster DM Healthcare Ltd is an primarily India based healthcare service provider. The Company operates in various segments of the healthcare enterprise, which consist of hospitals, clinics and retail pharmacies, and gives healthcare services to patients throughout economic segments in diverse gulf corporation council (GCC) states thru its various manufacturers, consisting of Aster, Medcare and Access. The Company's segments include Hospitals and Others. The Hospitals segment includes its hospitals and in-residence pharmacies at the hospitals. The Others segment includes the consultancy department, which provide healthcare consultancy. Its hospitals and clinics offer secondary and tertiary healthcare offerings to patients. In addition, it provide core medical, surgical and emergency services. Its hospitals additionally offer healthcare in numerous specialities, consisting of radiology, ophthalmology, orthopaedics and diverse care services.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2816 | 3192 | 807 | 841 | 929 | 955 | 974 | 1002 | 1086 | 1050 |
Other Income | 18 | 9 | 15 | 8 | 4 | 9 | 4 | 49 | 35 | 33 |
Total Income | 2835 | 3201 | 822 | 849 | 933 | 964 | 978 | 1051 | 1122 | 1083 |
Total Expenditure | 2497 | 2743 | 683 | 719 | 784 | 803 | 814 | 838 | 867 | 861 |
Operating Profit | 337 | 457 | 139 | 130 | 149 | 161 | 163 | 212 | 255 | 222 |
Interest | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 31 | 31 |
Depreciation | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24 |
Profit Before Tax | 71 | 172 | 61 | 54 | 64 | 79 | 75 | 123 | 161 | 105 |
Provision for Tax | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 37 |
Profit After Tax | 54 | 158 | 53 | 48 | 56 | 68 | 45 | 84 | 108 | 68 |
Adjustments | -8 | -19 | 118 | -43 | -87 | 111 | -69 | 5061 | -12 | -11 |
Profit After Adjustments | 46 | 139 | 171 | 5 | -31 | 179 | -24 | 5145 | 97 | 57 |
Adjusted Earnings Per Share | 0.9 | 2.8 | 3.4 | 0.1 | -0.6 | 3.6 | -0.5 | 103 | 1.9 | 1.1 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3876 | 5250 | 5931 | 6721 | 7963 | 8652 | 8608 | 10253 | 2994 | 3699 | 4112 |
Other Income | 23 | 25 | 37 | 45 | 35 | 38 | 50 | 51 | 37 | 25 | 121 |
Total Income | 3899 | 5275 | 5968 | 6767 | 7997 | 8690 | 8658 | 10304 | 3031 | 3724 | 4234 |
Total Expenditure | 3358 | 4789 | 5582 | 6089 | 7074 | 7363 | 7506 | 8720 | 2536 | 3112 | 3380 |
Operating Profit | 541 | 486 | 386 | 678 | 924 | 1327 | 1153 | 1584 | 495 | 612 | 852 |
Interest | 91 | 205 | 371 | 204 | 205 | 391 | 334 | 307 | 96 | 119 | 121 |
Depreciation | 144 | 243 | 322 | 298 | 306 | 586 | 618 | 641 | 192 | 220 | 242 |
Exceptional Income / Expenses | 0 | 0 | 416 | 130 | -2 | -20 | 0 | 0 | 0 | 0 | -24 |
Profit Before Tax | 306 | 38 | 108 | 308 | 410 | 330 | 205 | 637 | 195 | 261 | 464 |
Provision for Tax | 34 | 29 | 11 | 26 | 43 | 15 | 27 | 36 | 36 | 57 | 160 |
Profit After Tax | 272 | 8 | 98 | 282 | 367 | 315 | 178 | 601 | 160 | 205 | 305 |
Adjustments | -139 | -67 | 4 | -13 | -34 | -38 | -30 | -75 | 265 | -75 | 4969 |
Profit After Adjustments | 133 | -59 | 102 | 269 | 333 | 277 | 148 | 526 | 425 | 129 | 5275 |
Adjusted Earnings Per Share | 3.4 | -1.5 | 2.5 | 5.3 | 6.6 | 5.6 | 3 | 10.5 | 8.5 | 2.6 | 105.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 24% | -25% | -14% | 0% |
Operating Profit CAGR | 24% | -19% | -8% | 0% |
PAT CAGR | 28% | 5% | -11% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -3% | 33% | 20% | NA% |
ROE Average | 5% | 8% | 8% | 9% |
ROCE Average | 6% | 9% | 9% | 10% |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1484 | 420 | 1875 | 2832 | 3214 | 3272 | 3372 | 3953 | 4448 | 4560 |
Minority's Interest | 762 | 177 | 375 | 358 | 466 | 446 | 462 | 529 | 412 | 470 |
Borrowings | 612 | 2577 | 1891 | 1578 | 1966 | 1892 | 1755 | 1466 | 1312 | 446 |
Other Non-Current Liabilities | 312 | 602 | 462 | 488 | 615 | 3072 | 2835 | 3014 | 4008 | 1218 |
Total Current Liabilities | 1239 | 1967 | 2201 | 2224 | 2668 | 3722 | 3196 | 3559 | 4655 | 5831 |
Total Liabilities | 4409 | 5743 | 6804 | 7479 | 8928 | 12405 | 11620 | 12521 | 14836 | 17983 |
Fixed Assets | 2237 | 2507 | 3520 | 3738 | 4289 | 7124 | 6749 | 7009 | 9052 | 3175 |
Other Non-Current Assets | 372 | 730 | 812 | 872 | 1023 | 1186 | 1242 | 1416 | 862 | 642 |
Total Current Assets | 1801 | 2506 | 2472 | 2869 | 3617 | 4096 | 3629 | 4096 | 4922 | 7312 |
Total Assets | 4409 | 5743 | 6804 | 7479 | 8928 | 12405 | 11620 | 12521 | 14836 | 17983 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 248 | 248 | 253 | 131 | 192 | 225 | 115 | 235 | 299 | 365 |
Cash Flow from Operating Activities | 236 | 203 | 361 | 537 | 601 | 1223 | 1569 | 1314 | 1834 | 158 |
Cash Flow from Investing Activities | -448 | -786 | -1153 | -523 | -709 | -667 | -330 | -570 | -972 | -885 |
Cash Flow from Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1116 | -686 | -817 | 1053 |
Net Cash Inflow / Outflow | -10 | -5 | -138 | 61 | 26 | -119 | 123 | 58 | 45 | 326 |
Closing Cash & Cash Equivalent | 248 | 253 | 131 | 192 | 225 | 115 | 235 | 299 | 365 | 697 |
# | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 3.41 | -1.46 | 2.52 | 5.32 | 6.59 | 5.57 | 2.97 | 10.53 | 8.51 | 2.59 |
CEPS(Rs) | 10.71 | 6.23 | 10.42 | 11.47 | 13.34 | 18.13 | 16 | 24.86 | 7.04 | 8.5 |
DPS(Rs) | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Book NAV/Share(Rs) | 38.19 | 10.41 | 46.51 | 56.06 | 63.61 | 65.86 | 67.85 | 79.14 | 81.42 | 83.63 |
Core EBITDA Margin(%) | 13.36 | 8.79 | 5.89 | 9.41 | 11.16 | 14.9 | 12.81 | 14.95 | 15.29 | 15.86 |
EBIT Margin(%) | 10.25 | 4.62 | 8.08 | 7.62 | 7.73 | 8.33 | 6.26 | 9.2 | 9.73 | 10.28 |
Pre Tax Margin(%) | 7.9 | 0.72 | 1.83 | 4.58 | 5.15 | 3.81 | 2.38 | 6.21 | 6.53 | 7.06 |
PAT Margin (%) | 7.02 | 0.16 | 1.64 | 4.19 | 4.61 | 3.64 | 2.07 | 5.86 | 5.33 | 5.53 |
Cash Profit Margin (%) | 10.73 | 4.79 | 7.08 | 8.62 | 8.46 | 10.41 | 9.24 | 12.11 | 11.74 | 11.48 |
ROA(%) | 6.17 | 0.16 | 1.55 | 3.94 | 4.48 | 2.95 | 1.48 | 4.98 | 1.17 | 1.25 |
ROE(%) | 18.33 | 0.86 | 8.5 | 11.97 | 12.15 | 9.7 | 5.35 | 16.41 | 3.98 | 4.97 |
ROCE(%) | 15.42 | 7.69 | 11.45 | 10.43 | 11 | 11.77 | 9.03 | 15.96 | 4.52 | 5.76 |
Receivable days | 83.28 | 77.4 | 80.92 | 76.95 | 81.94 | 92.71 | 92.97 | 71.9 | 265.57 | 235.68 |
Inventory Days | 29.27 | 25.08 | 28.81 | 31.3 | 31.15 | 35.71 | 38.37 | 33.37 | 142.1 | 144.94 |
Payable days | 129.14 | 126.99 | 143.07 | 144.32 | 140.26 | 224.56 | 296.26 | 261.62 | 1195.85 | 1279.99 |
PER(x) | 0 | 0 | 0 | 31.42 | 23.44 | 17.14 | 46.19 | 18.69 | 28.39 | 158.09 |
Price/Book(x) | 0 | 0 | 0 | 2.98 | 2.43 | 1.45 | 2.02 | 2.49 | 2.97 | 4.89 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.49 |
EV/Net Sales(x) | 0.3 | 0.66 | 0.51 | 1.56 | 1.29 | 0.87 | 1.03 | 1.14 | 4.78 | 5.45 |
EV/Core EBITDA(x) | 2.17 | 7.11 | 7.79 | 15.49 | 11.1 | 5.68 | 7.68 | 7.35 | 28.9 | 32.98 |
Net Sales Growth(%) | 0 | 35.45 | 12.98 | 13.32 | 18.47 | 8.65 | -0.5 | 19.11 | -70.8 | 23.54 |
EBIT Growth(%) | 0 | -38.88 | 97.47 | 6.81 | 20.2 | 17.15 | -25.28 | 76.35 | -69.12 | 30.48 |
PAT Growth(%) | 0 | -96.98 | 1087.82 | 188.82 | 30.4 | -14.33 | -43.49 | 244.82 | -73.45 | 28.25 |
EPS Growth(%) | 0 | -142.88 | 272.36 | 110.88 | 23.89 | -15.55 | -46.61 | 254.26 | -19.22 | -69.57 |
Debt/Equity(x) | 0.73 | 7.91 | 1.47 | 0.83 | 0.87 | 0.91 | 0.68 | 0.55 | 0.52 | 0.42 |
Current Ratio(x) | 1.45 | 1.27 | 1.12 | 1.29 | 1.36 | 1.1 | 1.14 | 1.15 | 1.06 | 1.25 |
Quick Ratio(x) | 1.2 | 1.07 | 0.89 | 1.01 | 1.08 | 0.85 | 0.88 | 0.87 | 0.78 | 0.97 |
Interest Cover(x) | 4.37 | 1.18 | 1.29 | 2.51 | 3 | 1.84 | 1.61 | 3.08 | 3.04 | 3.19 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.28 | 0.36 | 0.62 | 0.34 | 0.22 | 0.19 | 0.09 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 37.88 | 37.88 | 41.88 | 41.88 | 41.88 | 41.88 | 41.88 | 41.88 | 41.88 | 41.88 |
FII | 9.17 | 42.49 | 38.64 | 38.81 | 40.21 | 41 | 33.48 | 27.08 | 23.85 | 22.62 |
DII | 11.59 | 8.92 | 8.94 | 8.63 | 7.64 | 7.15 | 13.7 | 16.35 | 20.91 | 22.91 |
Public | 41.36 | 10.7 | 10.55 | 10.68 | 10.26 | 9.97 | 10.94 | 14.69 | 13.36 | 12.59 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 18.92 | 18.92 | 20.92 | 20.92 | 20.92 | 20.92 | 20.92 | 20.92 | 20.92 | 20.92 |
FII | 4.58 | 21.22 | 19.3 | 19.39 | 20.09 | 20.48 | 16.72 | 13.52 | 11.91 | 11.3 |
DII | 5.79 | 4.46 | 4.46 | 4.31 | 3.82 | 3.57 | 6.84 | 8.17 | 10.44 | 11.44 |
Public | 20.66 | 5.35 | 5.27 | 5.34 | 5.13 | 4.98 | 5.46 | 7.34 | 6.67 | 6.29 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 | 49.95 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About